Cargando…
Radioiodinated PARP1 tracers for glioblastoma imaging
BACKGROUND: Although the understanding of the genetic and molecular basis of cancer has advanced significantly over the past several decades, imaging and treatment options for glioblastoma patients have been more limited (N Engl J Med 359:492-507, 2008). This is in part due to difficulties in diagno...
Autores principales: | Salinas, Beatriz, Irwin, Christopher P., Kossatz, Susanne, Bolaender, Alexander, Chiosis, Gabriela, Pillarsetty, Nagavarakishore, Weber, Wolfgang A., Reiner, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559561/ https://www.ncbi.nlm.nih.gov/pubmed/26337803 http://dx.doi.org/10.1186/s13550-015-0123-1 |
Ejemplares similares
-
The Unique Pharmacometrics of Small Molecule Therapeutic Drug Tracer Imaging for Clinical Oncology
por: Dunphy, Mark P. S., et al.
Publicado: (2020) -
PARPi-FL - a Fluorescent PARP1 Inhibitor for Glioblastoma Imaging
por: Irwin, Christopher P., et al.
Publicado: (2014) -
Detection and Delineation of Oral Cancer With a PARP1-Targeted Optical Imaging Agent
por: Kossatz, Susanne, et al.
Publicado: (2017) -
Optical Imaging of PARP1 in Response to Radiation in Oral Squamous Cell Carcinoma
por: Kossatz, Susanne, et al.
Publicado: (2016) -
Target engagement imaging of PARP inhibitors in small-cell lung cancer
por: Carney, Brandon, et al.
Publicado: (2018)